Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Farolfi

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Cancers|March 6, 2021
Immunotherapy and Its Development for Gynecological (Ovarian, Endometrial and Cervical) Tumors: From Immune Checkpoint Inhibitors to Chimeric Antigen Receptor (CAR)-T Cell TherapyGiuseppe Schepisi, Chiara Casadei, Ilaria Toma, et al.
Iscience|April 22, 2024
Endometriosis and endometrial cancer: A propensity score-adjusted real-world data studyAlberto Farolfi, Nicola Gentili, Sara Testoni, et al.
Frontiers in Endocrinology|March 13, 2019
Psychosocial Issues in Long-Term Survivors of Testicular CancerGiuseppe Schepisi, Silvia De Padova, Delia De Lisi, et al.
Frontiers in Pharmacology|December 21, 2020
Hydroxychloroquine as Prophylaxis for COVID-19: A ReviewManuela Monti, Bernadette Vertogen, Carla Masini, et al.
Frontiers in Oncology|September 25, 2020
Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinoma <i>in situ</i>Alberto Farolfi, Elisabetta Petracci, Luigi Serra, et al.
Breast Cancer Research and Treatment|May 28, 2015
Efficacy of endocrine therapy in relation to progesterone receptor and Ki67 expression in advanced breast cancerAndrea Rocca, Alberto Farolfi, Roberta Maltoni, et al.
Cancers|November 27, 2025
Pharmacological Prevention in Breast Cancer: Current Evidence, Challenges, and Future DirectionsSamanta Sarti, Alessandro Adriano Viansone, Olga Serra, et al.
The Prostate|June 29, 2019
Testosterone levels and androgen receptor copy number variations in castration-resistant prostate cancer treated with abiraterone or enzalutamideCristian Lolli, Delia De Lisi, Vincenza Conteduca, et al.
Journal of Oncology|October 24, 2019
Inflammatory Biomarkers as Predictors of Response to Immunotherapy in Urological TumorsGiuseppe Schepisi, Nicole Brighi, Maria Concetta Cursano, et al.
European Journal of Cancer (Oxford, England : 1990)|July 30, 2016
Systematic versus on-demand early palliative care: results from a multicentre, randomised clinical trialMarco Maltoni, Emanuela Scarpi, Monia Dall'Agata, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Cancers|March 6, 2021
Immunotherapy and Its Development for Gynecological (Ovarian, Endometrial and Cervical) Tumors: From Immune Checkpoint Inhibitors to Chimeric Antigen Receptor (CAR)-T Cell TherapyGiuseppe Schepisi, Chiara Casadei, Ilaria Toma, et al.
Iscience|April 22, 2024
Endometriosis and endometrial cancer: A propensity score-adjusted real-world data studyAlberto Farolfi, Nicola Gentili, Sara Testoni, et al.
Frontiers in Endocrinology|March 13, 2019
Psychosocial Issues in Long-Term Survivors of Testicular CancerGiuseppe Schepisi, Silvia De Padova, Delia De Lisi, et al.
Frontiers in Pharmacology|December 21, 2020
Hydroxychloroquine as Prophylaxis for COVID-19: A ReviewManuela Monti, Bernadette Vertogen, Carla Masini, et al.
Frontiers in Oncology|September 25, 2020
Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinoma <i>in situ</i>Alberto Farolfi, Elisabetta Petracci, Luigi Serra, et al.
Breast Cancer Research and Treatment|May 28, 2015
Efficacy of endocrine therapy in relation to progesterone receptor and Ki67 expression in advanced breast cancerAndrea Rocca, Alberto Farolfi, Roberta Maltoni, et al.
Cancers|November 27, 2025
Pharmacological Prevention in Breast Cancer: Current Evidence, Challenges, and Future DirectionsSamanta Sarti, Alessandro Adriano Viansone, Olga Serra, et al.
The Prostate|June 29, 2019
Testosterone levels and androgen receptor copy number variations in castration-resistant prostate cancer treated with abiraterone or enzalutamideCristian Lolli, Delia De Lisi, Vincenza Conteduca, et al.
Journal of Oncology|October 24, 2019
Inflammatory Biomarkers as Predictors of Response to Immunotherapy in Urological TumorsGiuseppe Schepisi, Nicole Brighi, Maria Concetta Cursano, et al.
European Journal of Cancer (Oxford, England : 1990)|July 30, 2016
Systematic versus on-demand early palliative care: results from a multicentre, randomised clinical trialMarco Maltoni, Emanuela Scarpi, Monia Dall'Agata, et al.
Pageof 7